Banishree Saha
Biomarker and translational medicine leader with 20+ years of experience across hepatology, immune-mediated diseases, and oncology. Specializes in building end-to-end clinical biomarker strategies—from scientific rationale and endpoint selection to assay development/validation, operational execution, and data interpretation—to drive evidence-based decisions in clinical programs.
Provides strategic oversight of biomarker assay technologies supporting gastrointestinal and inflammation development portfolios, partnering with research, clinical, and operational teams to ensure analytical rigor, data quality, and regulatory readiness. Recognized for leading cross-functional, matrix teams and external collaborations to deliver high-confidence biomarker readouts that strengthen program strategy, accelerate development timelines, and support impactful clinical outcomes.
Sessions
-
Integrating Transcriptomics and Proteomics to Accelerate Biomarker Discovery and Clinical Translation03-Jun-2026Multi-Omics Integration Stage